Source: sec

Centrose: Centrose Raises Funding

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

President & CEO

James R. Prudent

CEO Approval Rating

90/100

Centrose is a biopharmaceutical company that develops and commercializes small molecular drug therapeutics for the treatment of cancer.